Objectives: To evaluate the feasibility and long-term compliance with a low-fat diet supplemented with soy protein in men at increased risk for recurrence after radical prostatectomy. Design: Randomized, control study. Setting: Academic center in USA. Subject: Forty men who had undergone radical prostatectomy and were at increased risk for recurrence. Intervention: Low-fat (15% fat), high-fiber (18 g/1000 kcal) diet supplemented with 40 g soy protein isolate (n ¼ 26) was compared to USDA recommended diet (n ¼ 14). Results: Over 4 years, subjects in the intervention group but not in the control group made and sustained significant changes in their diet as measured by the dietary assessment instruments and urinary isoflavone excretion. In the intervention group, dietary fat intake was reduced from 33.4671.27% energy/day to 21.0471.74% (Po0.05), fiber intake increased from 14.671.06 to 21.0572.29 g/day. The insulin growth factor-1 (IGF-1) level was decreased from 260.478.6 ng/ml at baseline to 220.577.9 ng/ml at 6 months (Po0.05) in the intervention group with no significant change in the control group. An ex vivo assay demonstrated inhibition of LNCaP cell growth (À20.077.7%, Po0.05) by sera from patients in the intervention group after 6 months of dietary change compared to baseline. Conclusion: These data suggest that long-term low-fat dietary interventions as part of prospective randomized trials in prostate cancer survivors are feasible, and lead to reductions in circulating hormones or other growth factors stimulating prostate cancer growth ex vivo.
Introduction
Prostate cancer is the most common non-cutaneous malignancy in US males and remains the second leading cause of cancer death despite recent advances in screening, early detection and treatment. It was estimated that 30 350 men would die of prostate cancer (Jemal et al., 2005) . Although the majority of newly diagnosed patients present with nonmetastatic disease, the primary treatments available such as radical prostatectomy and radiation therapy continue to have a significant 30% failure rate (Trapasso et al., 1994; Khuntia et al., 2004) . Androgen deprivation therapy for biochemical recurrence is associated with significant morbidity and impact on quality of life, including fatigue, hot flashes, loss of libido, decreased muscle mass and osteoporosis with long term use. Strategies to delay clinical prostate cancer progression and prolong the interval from treatment failure to hormonal ablation would be of paramount importance.
Despite its prevalence, the origins of prostate cancer and the factors that promote its progression are not well established. There is a great deal of evidence that prostate cancer may be the result of genetic-environmental interactions in which an important environmental factor is the dietary and lifestyle characteristics of Western industrialized nations (US Cancer Statistics Working Group, 2003) . Although latent or clinically insignificant prostate cancer occurs in a large and equal proportion of men in autopsy studies in both Asian countries and the US, the rate of clinically significant prostate cancer is much higher in the US (Jemal et al., 2005) . Furthermore, Chinese and Japanese men who immigrate to the US have a higher incidence of and mortality from prostate cancer than Chinese and Japanese men in their native country (Shimizu et al., 1991; Whittemore et al., 1995) . In Japan, the incidence of prostate cancer has been increasing concomitant to the adoption of Western diets and lifestyles (Boyle et al., 1993) . The same dietary and lifestyle factors which may play a role in the development of prostate cancer have been shown to affect tumor progression and metastasis (Wynder et al., 1994) . Two such factors include the high-fat diet consumed in the US combined with a sedentary lifestyle. The international data show a positive correlation between dietary fat and the incidence of prostate cancer (Hebert et al., 1998) . In addition animal studies show that tumor cells grow at an increased rate when the fat content of the diet is increased (Kondo et al., 1994; Wang et al., 1995) and that a low-fat diet will increase the time to the development of androgen independence of human tumor xenografts in a castrated SCID mouse (Ngo et al., 2004) . In previous studies, we reported that serum-stimulated growth of LNCaP prostate tumor cells was reduced following a very-low-fat diet and exercise (Tymchuk et al., 2001) .
Soy protein isoflavones found in negligible amounts in the US diet are potent inhibitors of prostate cancer growth (Peterson and Barnes, 1993) and consumption of soy food has been associated with a lower risk of prostate cancer in men (Yan and Spitznagel, 2005) . Decreased prostate cancer risk has also been found in 7th day Adventist men who have high intakes of beans, lentils and peas (Mills et al., 1989) , and in men of Japanese ancestry in Hawaii who eat tofu and soybean products that contain significant quantities of isoflavones (Severson et al., 1989; Adlercreutz et al., 1991) .
This feasibility study was designed to provide support for the development of a national multicenter trial of nutrition intervention for the prevention of prostate cancer progression. We designed a 4-year prospective randomized study with the primary aim being compliance at 4 years with a low-fat, high-fiber diet supplemented with soy protein in a well-defined subgroup of patients who have undergone radical prostatectomy and were at a high risk for having residual prostate cancer. The secondary aims of this study were to demonstrate the effects of the above nutritional intervention on prostate specific antigen (PSA), lipid and hormone levels and prostate cancer cell growth through use of an ex vivo assay.
Research design and methods

Subjects
Forty patients 40-75 years old who had undergone a radical prostatectomy and bilateral pelvic lymph node dissection for adenocarcinoma of the prostate, and (1) were at high risk for having residual cancer based on specific pathologic criteria in the radical prostatectomy specimen (combined Gleason score X7, or tumor invasion through the prostate capsule, or tumor invading the seminal vesicles, or tumor extending into the inked margin on the prostate surgical specimen), (2) had an undetectable PSA of o0.4 ng/ml (Tandem-R, Hybritech) and (3) had not received adjuvant radiation or hormonal therapy were recruited for this protocol.
Study protocol
The study protocol was approved by the Human Subjects Protection Committee and informed consent was obtained from all subjects before study enrollment. Subjects were randomized to control and intervention groups with a ratio of 2:1 into the low-fat diet vs control group.
Diet intervention
The low-fat intervention group received dietary instruction on consuming a low-fat (15% of total energy from fat) diet, high in fiber (18 g/1000 kcal) from 5 to 8 servings of fruits, vegetables, 8-11 servings of cereals and grains, supplemented with 40 g of soy protein isolate (Take Care AB-20, the Solae Company, St Louis, MO, USA) providing isoflavones (40 mg genistein). Patients attended individual counseling sessions lasting approximately 30 min (weeks 1, 2, 3, 4, 5, 6, 7, 8 , then monthly at months 3-48) with a research dietitian at the UCLA Center for Human Nutrition. The control group received education materials on the USDA Food Guide Pyramid and the current US. Dietary Guidelines recommending 30% of calories from fat.
Twenty-four hour urine collections were obtained for measurement of total genistein levels as a marker of compliance with soy intake at months 3, 6 then every 6 months. Percent fat calories in the diet was estimated in both groups at 3 months, 6 months and every 6 months during the trial using the Fred Hutchinson Food Frequency Questionnaire (FHFFQ) validated for estimating fat intake. In both groups, weight, height, waist-to-hip measurements and bioelectrical impedance were carried out at the baseline at 6-month intervals, as well as PSA, hormone, lipid and 24 h urinary genistein levels for all the 4 years.
Cell culture assay
Blood samples from six subjects in each group were randomly selected to conduct the cell culture assay. Fasting blood was obtained from the subjects and was transported on ice to the laboratory and the serum was separated by centrifugation and stored at À801C until analyzed.
The serum from patients was incubated for 48 h with LNCaP cells using cell culture assay as described (Tymchuk et al., 2001b) . Viable cells were counted to evaluate whether the bioassay detected a change in serum stimulated growth. LNCaP (American Type Culture Collection Rockville, MA, USA) was cultured in RPMI 1640 medium without phenol red and supplemented with 10% fetal bovine serum, 200 IU penicillin, 200 mg/ml streptomycin and 4 mM L-glutamine in humidified incubators maintained at 371C in 5% CO 2 . The same lot of fetal bovine serum was used for all experiments. Cells were passaged routinely at a confluence of 85-90% and the medium was changed every 3 days. All cell culture experiments were performed within a specific range of passages (LNCaP 24-34). Routine passaging involved trypsinization with a 0.25% trypsin-0.1% ethylenediaminetetra acetic acid mixture to remove cells from the wall of the flasks, followed by trypsin quenching with medium and centrifugation at 1250 r.p.m. for 5 min.
For cell culture assay cells were transferred to six-well plates at a predetermined density of 5 Â 10 5 LNCaP and 4 Â 10 5 PC-3 cells, and allowed to attach to the flask for 24 h. Range of variation of the number of cells placed in each well was 5%, as determined by counting cells at 24 h (data not shown). At 24 h the culture medium was replaced by medium with the composition described except 10% fetal bovine serum was replaced with 10% subject serum for a total of 2 ml per well. Each serum sample was run in triplicate. Pre-intervention and post-intervention samples of individuals were run in one experiment to minimize interassay variability. LNCaP cells were grown for 48 h in 10% fetal bovine serum supplemented medium per experiment to allow for comparison among experiments. Cells were harvested by trypsinization and centrifugation 48 h after the addition of medium containing fetal bovine serum or subject serum. Cells from each well were then resuspended in medium and counted using Trypan blue dye and a hemocytometer. The personnel performing the cell counting were blinded to whether the serum was obtained before or after intervention as well as to subject identity. To validate further the method experiments were repeated on 2 days in triplicate using serum from three long-term subjects. Insulin growth factor-1 (IGF-1), insulin growth factor binding protein-1 (IGFBP-1) Serum IGF-1, IGFBP-1 and insulin levels were measured in duplicates by ELISA (Diagnostic System Laboratories Inc., Webster, TX, USA). All assays were performed in a blinded manner, and control samples provided by the manufacturer were included in each run. IGF-1 was separated from its binding proteins in serum prior to measurement. The antibodies used show no cross-reactivity with other components of the IGF axis.
Prostate specific antigen assay PSA testing was performed by the UCLA Brentwood Clinical Lab. Analytic sensitivity assays performed by the Brentwood Lab show that the lowest PSA level that this lab can most accurately detect is a PSA of 0.5 ng/ml (Tandem-R, Hybritech).
Urine daidzein and genistein
Urinary isoflavone concentrations were determined by high-pressure liquid chromatography (HPLC) in the CNRU Nutritional Biomarker Core Laboratory at UCLA. Flavone was used as an internal standard (Huang et al., 2000) . A Waters Novapak C18 column 150 Â 3.9 mm (Milford, MA, USA) combined with a Vydac C18 guard column (Alltech, Deerfield, IL, USA) was used in an Agilent Technologies1050 HPLC System (Wilmington, DE, USA). This method was used to determine urinary genistein levels in humans before and after soybean intake as a marker of dietary adherence. Urinary creatinine was determined after reaction with picric acid in alkaline conditions to form a color complex that absorbs at 510 nm using the reagent kit from Pointe Scientific Inc. (Lincoln Park, MI, USA). The rate of formation of color was proportional to the creatinine in the sample.
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Statistical procedures
This was a two-arm prospective randomized design comparing two groups, an intensive intervention group and a control group. We compared % fat calorie measurements by FHFFQ at 3 months, 6 months and every 6 months thereafter until 4 years. The primary end point is the comparison of the difference between % fat calories of the two groups at 1 year. Additional secondary analysis studied the changes from baseline to each of the time points (3 months, 6 months and every 6 months until 4 years) of the outcome variables which included % fat calorie, weight, blood and urine lab results within each treatment group and between the two groups. For these major outcome variables, the trend over time was explored within each group and the pattern of the trend over time was compared between the two groups using graphic methods and repeated measures analysis. The sample size was chosen to have 85% power, a ¼ 0.05, level of significance with the following parameters:
Control values obtained by the National Health Survey, using a two-tailed t-test for two independent groups with a power of 85%. The trial was unbalanced in sample size. There is a 2:1 allocation of patients to intervention and control groups. Patients were randomized using a random permuted block design.
The main objective was to see if this type of patient would adhere to a low-fat diet. In our previous study (Women's Health Trial and Women's Invention Nutrition Study), when using a target of 15% fat intake, the achieved fat intake is usually calculated at 22% intake. Therefore, a conservative analysis was made using the change to 25% fat intake for the purpose of a power calculation. Secondary endpoints were studied via paired t-tests and correlational analysis (Wilcoxon test).
Results
Twenty-five out of 40 subjects completed the 4-year study. Four subjects dropped from the control group after randomization. Three subjects from the control group and seven from the intervention group dropped from the study owing to time conflict, transportation problem and relocation. One subject in the control group died from recurrent colon cancer at month 24. There were four subjects dropped after randomization, three within the first 3 months, one at 6 month and two at 12 month. There was no dropout after the first year. The baseline characteristics of the subjects are summarized in Table 1a and b. Both groups were well matched demographically.
Anthropometric
In the intervention group, the body weight and body mass index (BMI) were all significantly lower than baseline from 3 to 36 months and body fat was significantly lower than baseline at months 3, 6, 12, 18, 36 and 42. In the control group, the weight was significantly higher than baseline at month 30 and BMI was significantly higher at months 30 and 48. Compared to the control group, the intervention group had lower percentage of body fat and waist/hip ratio, most notably at month 12 for body fat and at months 30 and 48 for waist/hip ratio (Table 2) .
Dietary intake by FFQ There were no significant differences between the intervention and control groups in the intake of nutrients from food at baseline (Table 3a) . By the end of month 3, however, intervention participants had made significant dietary changes as planned relative to the control group, which was sustained throughout the trial. Generally, changes in the intervention group were consistent with the study dietary goals.
The energy intake at baseline was 17557175.42 kcal/day for the control group and 18307107.84 kcal for the intervention group. There was a significant decrease of energy intake from baseline in the intervention group for the first 3 years (3297147 kcal decrease at end of year 1, 3257150.5 kcal at year 2, 327.97144 kcal at year 3, Po0.05) but not at the end of the study (163.07165 kcal decrease at year 4). There was also downward trend in the energy intake in the control group but this was not significantly different from the baseline. There was no significant difference in energy intake between the two study groups.
Total dietary fat intake decreased dramatically for the intervention group at year 1, 2, 3 and 4 years whereas fat intake in the control group remained constant. Dietary fat intake of the intervention group was significantly lower than that of the control group at all time points. Ingestion of all types of dietary fats including cholesterol, monounsaturated, polyunsaturated and saturated fat were decreased in the intervention group but not in controls.
Dietary intakes of fiber from grains, fruits and vegetables were increased in the intervention group. As a result of the increased intake of fruits and vegetables, intakes of vitamin C, and b-carotene from food also increased significantly. In contrast, vitamin E from food decreased significantly in the intervention but not control groups most likely owing to a decrease in the intake of vegetable oils. However, differences in vitamin E intake between the control and intervention groups were not significantly different at any time point (see Table 3b ).
The protein intake from foods was 69.6376.60 g/day for the control group and 68.9674.25 g for the intervention group at the baseline. There was not any significant change of protein intake from food during the entire study. The total intake of protein in the intervention group was 40 g higher (Po0.05) when the soy supplement is accounted for. Therefore, there was no decrease in the intake of protein exclusive of the soy supplement in the intervention group.
Biological markers
The mean plasma cholesterol levels at baseline and at years 1-4 for the control and intervention participants are shown in Table 4 . The total cholesterol levels were decreased from the baseline in the intervention group during the 4-year study period but the statistic significance presented for years 1-3. There were no significant changes during the study in the control group at any time point or at year 4 in the intervention group. The baseline HDL level in the intervention group was significantly higher than the control group but there was not any difference between the groups during the study after the baseline difference was adjusted.
We observed a marked increase in genistein and daidzein urinary excretion in the intervention group while there was no change for the control group over the 4 years (Table 4) . Isoflavone excretion was significantly higher at all time points in the intervention group compared with control group demonstrating ongoing compliance with the protein supplements in the intervention group over 4 years. One subject in the control group had elevated level of isoflavones throughout the study suggesting purposeful but secret cross-over.
All the subjects had PSA o0.2 at the time of randomization. In the intervention group the PSA level of one subject rose to 0.5 at 12 month, 0.7 at 18 month then he was lost follow-up. Another subject in the intervention group had a PSA of 0.4 at end of the study. The PSA level remained o0.2 for rest of the subjects in both intervention groups for the 48 month study period. There was no significant change from baseline for total testosterone in either group. The testosterone level for the intervention group was significantly higher than the control group at month 42 but not any other time point. No significant change in SHBG in either group was seen after 6 months ( Figure 1a) .
IGF-1, IGFBP-1 and insulin were measured at baseline and 6 month (Figure 1b, c, d ). The IGF-1 level was decreased from 260.478.6 ng/ml at baseline to 220.577.9 at 6 month (Po0.05) in the intervention group while only changing from 262.978.6 to 259.5714.3 g/ml in the control group. The level of IGF-1 at 6 month was significantly lower in the Feasibility of a low-fat/high-fiber diet intervention Z Li et al intervention group compared with control group (P ¼ 0.04).
There was no significant change from baseline nor any difference between groups in insulin and IGFBP-1 levels.
Cell culture assay
Plasma from six randomly selected subjects in the control group and six subjects in the intervention group were tested for their ability to inhibit LNCaP cell growth in an established ex vivo cell culture assay. Significant inhibition of LNCaP cell growth was observed (À20.077.7%, Po0.05) with sera from patients after 6 months of a low-fat diet compared to baseline, whereas sera from the control group did not test differently at baseline and 6 months ( Figure 2) .
Discussion
There is a substantial body of epidemiologic, experimental and metabolic studies providing evidence supporting the notion that diet may influence prostate cancer development, progression, metastasis and mortality (Rose and Connolly, 1992; Hebert et al., 1998) . The primary end point of this study was to determine whether dietary intervention in the form of a low-fat, high-fiber diet in combination with soy supplementation was a feasible long-term approach for freeliving subjects with prostate cancer for long term.
Success in multifactor dietary change
Our study succeeded in achieving a long-lasting change in dietary pattern. Global dietary interventions fell into disfavor following the failure of a large NCI-supported trial in men and women with colon polyposis (Lanza et al., 2001) . The above trial had enrolled predominantly men, comprising two-thirds of the subjects. Our nutrition intervention was similar to the one in the Colon Polyposis Trial, emphasizing a low-fat, high-fiber diet enriched in fruits and vegetables. Shike et al. (2002) reported that there was no change in the incidence of prostate cancer in men participating in this trial . However, this study did not select men at risk of prostate cancer recurrence as in the present study, and so cannot be considered definitive. Ornish et al. (2005) conducted a randomized, prospective clinical trial on men with clinically localized prostate cancer who selected 'watchful waiting' as their primary therapy. Patients in the intervention group were asked to eat a lowfat, soy-supplemented vegan diet combined with intensive lifestyle changes. Subjects in this trial were compliant with the intervention over 1-year-period.
Intake information from dietary assessment instrument FFQ indicated that our dietary plan did result in multifactorial dietary changes in the intervention group. The urinary excretion of genistein and daidzein were significantly elevated in all the subjects in the intervention group. The consistency of the isoflavone results together with FFQ data provides assurance that the estimated amount of change was accurate and sustained.
Because dietary interventions cannot be blinded and dietary assessments rely on self-report, we also looked for reasonable biological measures to ascertain adherence. Although there are no perfect biomarkers for the dietary changes, plasma and serum cholesterol are considered effective markers of a low-fat, low-saturated-fat diet and plasma. The cholesterol level was Feasibility of a low-fat/high-fiber diet intervention Z Li et al significantly lowered from baseline in the intervention group but there was no significant difference in cholesterol concentrations between the intervention and control groups during the entire 4 years of the trial. The lack of a difference between groups may be due to the small sample size of the control group in the study. There was continued increase in weight in the control which is a secular trend while the low-fat diet resulted in modest weight loss even though that was not the goal as has been seen in other low-fat trials. It is another indicator that men were compliant. In contrast with other long-term trials in which participants did not maintain changes made during the first 6-12 month over subsequent years (Jeffery et al., 1984; Elmer et al., 1995) , the intervention participants sustained dietary changes for the entire 4 years. This study combined counseling with the proven techniques of self-monitoring, social support and behavior modification to achieve dietary change (Lanza et al., 2001) .
Soybean protein isolate
Soy protein isoflavones are components of soy protein isolate in known amounts, whereas soy protein included in processed foods often has been extracted chemically so that the isoflavones are no longer present. Soy foods have been a part of Asian cuisine for centuries, but only within the past several decades have soy products become a part of Western culture. Although soy protein products are added to hundreds of foods, their nutritional contribution is of minor consequence as they are usually functional ingredients. Traditional Asian foods such as tofu and miso soup are consumed in small amounts if at all in the American diet. There is no toxicity associated with the use of soy protein isolates, and these products provide a measured means of adding isoflavones to the diet for clinical trials. The product chosen for this study Protein Technologies, St. Louis, MO, USA) has been employed in a number of human studies and has been shown to be absorbed and to provide adequate amounts of genistein to model that obtained from a traditional Asian diet. It is primarily in the form of a malonyl ester which is cleaved in the large bowel and absorbed into the circulation where it is sulfated or glucuronidated in the liver. Once it is excreted in the bile it is recirculated via the enterohepatic circulation so that its dietary consumption can be monitored by measurement of urinary isoflavone conjugates. It is prepared as an unflavored powder, which can be mixed with fruit juices or other liquids. Further these can be mixed with various fruits to further enhance compliance.
Effect on sex hormone and IGF-1 axis A number of mechanisms may explain the reduction in the LNCaP cell growth after the dietary intervention. Testosterone is known to stimulate LNCaP cell growth. However, in our study, we did not detect any significant change of testosterone level during the 4-year duration. Feasibility of a low-fat/high-fiber diet intervention Z Li et al
Epidemiological investigations have found a positive correlation between elevated serum IGF-I levels and the risk of developing prostate cancer (Chan et al., 1998; Stattin et al., 2000) . Tissue levels of IGF-1 appear to be a critically important factor during initiation and progression of prostate cancer (Kaplan et al., 1999) . Our group found previously that serum from men consuming a low-fat diet combined with exercise reduced the growth of LNCaP cells in vitro through decreased serum levels of IGF-I and increased serum IGF binding protein-I relative to serum from control untreated men (Ngo et al., 2002) . The current study demonstrated that the IGF-1 level was significantly decreased with the dietary intervention at 6 months.
The activity of IGF-1 is modulated by six high-affinity binding proteins . Among these binding proteins, IGFBP-1 is known to be nutritionally regulated with serum levels highest in the fasting state and lowest in the fed, high-insulin state (Collett-Solberg and Cohen, 1996; Ferry et al., 1999) . In the current study, we did not observe any change in insulin levels nor IGFBP-1 levels in either group in 6 months.
Inhibitory effect on prostate cancer cell growth
We determined whether our dietary intervention would result in serum changes that reduce the growth of prostate cancer cell lines in vitro. In our study, 6-month postintervention serum reduced the growth of androgen-dependent LNCaP prostate cancer cells by 20% compared with baseline serum from the same subjects in the intervention group but not the control group. These results suggest that the dietary intervention in the current study impacted on levels of serum growth factors that potentially affect prostate cancer progression.
This study showed that free-living individuals could alter their eating patterns in significant ways given appropriate support. The main limitation to generalizing our findings was small sample size. In addition, participants with a diagnosed prostrate cancer that may be more highly motivated than the general population. Clinical trial volunteers also tend to be of a higher socio-economic status and more highly educated than nonparticipants (Table 1) , which may affect motivational constellation and the ability to make long-term changes. However, the control subjects, who had equal reason to change, did not, despite a wealth of nutrition information provided by the media and an initial dietary pamphlet.
Dropout rate
The dropout rate for the present study was 15/40 and all dropouts occurred during the first year of the trial. This represents an important observation from our pilot study and suggests that a lead in period should be incorporated into future long-term trials that incorporate dietary fat modification in men with prostate cancer. On the basis of Feasibility of a low-fat/high-fiber diet intervention Z Li et al the present trial, we would suggest a 3-month lead in as this would account for 17.5% of the dropouts. Feasibility of a low-fat/high-fiber diet intervention Z Li et al
